Liposomal Delivery TRIZ Cases

A vacuum-driven porous membrane setup uses disposable plastic parts to speed liposome extrusion, cut cleaning time, and reduce cross-contamination.

Encapsulating uric acid in liposomes prevents crystallization, enables brain delivery, and lowers kidney risk in stroke treatment.

CD44-targeted cerasomes improve vulnerable plaque detection and drug delivery by combining specific binding with stable, sustained release.

Blocking DNA-PK with an imidazolinone derivative helps doxorubicin overcome tumor DNA repair and shrink tumors with minimal toxicity.

Vacuum-driven liposome extrusion with disposable plastic membrane holders cuts cleaning time, limits cross-contamination, and improves size consistency.

PEG-coated solid lipid nanocarriers protect dual cART drugs, penetrate nasal mucus, and support nose-to-brain delivery across the BBB.

A W/O/W emulsion, sparging, and microfiltration process raises bupivacaine MVL yield while preserving release stability during storage.

EGFR-targeted LNPs enable placenta-selective mRNA delivery and transient VEGF expression to improve placental vasodilation without viral integration risks.

Specific PEG-lipid ratios help LNPs preserve mRNA functionality and formulation stability during refrigerated storage for at least six months.

Extended bolus intervals reduce microvesicle use while preserving therapeutic efficacy.

Controlled membrane emulsification, stabilization, concentration, and filtration reduce batch variability in particle production.

Thin film evaporation with microfiltration and diafiltration produces stable, bioequivalent bupivacaine MVLs at commercial scale.

This case uses ionic liquids in LNPs to improve BBB penetration, reduce liver and spleen accumulation, and enable brain delivery.

Ionizable colloid-forming active substance complexes nucleic acids to resolve poor small molecule loading and sub-optimal RNA delivery.

PAN-811 thiosemicarbazone compounds act as antioxidants to protect central nervous system neurons from chemotherapy-induced damage.

Amphipathic polymers encircle lipid bilayers to extract membrane proteins, avoiding detergent-induced inactivation and aggregation.

A coaxial microfluidic device hydrodynamically focuses amphiphilic molecules between aqueous streams to form unilamellar lipid vesicles.

Nanoparticles protect mRNA from enzymatic degradation to overcome static and dynamic eye barriers.

Engineered extracellular vesicles use surface targeting moieties to direct therapeutic cargo toward specific central nervous system tissues.

Ligand-targeted cationic liposomes deliver temozolomide across the blood-brain barrier, overcoming MGMT-mediated resistance in glioma treatment.

Compressible polyimide beads dynamically adjust density to maintain optimal annulus pressure between pore and fracture gradients.

Frontal collision of organic and aqueous streams at raised pressure in a jet impingement reactor yields scalable, reproducible lipid nanoparticle dispersions.

Microfluidic mixing replaces multi-step preparation to form uniformly sized cationic lipid nanocarriers, reducing production costs and environmental pollution.

Modified maleic acid copolymers form stable nanodiscs to solubilize membrane proteins from galactolipid-rich membranes.

A microcapsule shell encapsulates a microbubble to provide ultrasound contrast and controlled drug delivery.